encainide has been researched along with Cardiac Failure in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (46.67) | 18.7374 |
| 1990's | 8 (53.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, JL; Carlson, M; Davies, R; Duff, HJ; Greene, HL; Hallstrom, AP; Huther, M; Kammerling, JM; Romhilt, DW | 1 |
| DeMaria, A; Gottlieb, S; Greene, HL; Hallstrom, A; Huther, M; Pratt, CM; Young, JB | 1 |
| Dwyer, EM; Echt, DS; Greenberg, HM; Hochman, JS; Peters, RW; Steinberg, JS | 1 |
| Arensberg, D; Baker, A; Barker, AH; Echt, DS; Friedman, L; Greene, HL; Liebson, PR; Mitchell, LB; Obias-Manno, D; Peters, RW | 1 |
| Capone, RJ; el-Sherif, N; Geraci, TS; Handshaw, K; Morganroth, J; Pawitan, Y; Schlant, RC; Waldo, AL | 1 |
| Hammermeister, KE | 1 |
| Gottlieb, SS; Kukin, ML; Medina, N; Packer, M; Yushak, M | 2 |
| Thomis, JA | 1 |
| Barker, AH; Capone, RJ; Echt, DS; Greene, HL; Hallstrom, AP; McBride, R; Richardson, DW; Roden, DM | 1 |
| Lampert, S; Lown, B; Podrid, PJ; Ravid, S | 1 |
| Gottlieb, SS | 1 |
| Echt, DS; Roden, DM; Woosley, RL | 1 |
| Soyka, LF | 1 |
2 review(s) available for encainide and Cardiac Failure
| Article | Year |
|---|---|
Encainide--an updated safety profile.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Heart Conduction System; Heart Failure; Humans | 1990 |
Effects of congestive heart failure on the pharmacokinetics and pharmacodynamics of antiarrhythmic agents.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Digitalis; Disopyramide; Drug Interactions; Encainide; Flecainide; Half-Life; Heart Failure; Hemodynamics; Humans; Kidney; Kinetics; Lidocaine; Liver; Piperidines; Plants, Medicinal; Plants, Toxic; Potassium; Procainamide; Quinidine; Regional Blood Flow; Tocainide | 1986 |
9 trial(s) available for encainide and Cardiac Failure
| Article | Year |
|---|---|
Time to arrhythmic, ischemic, and heart failure events: exploratory analyses to elucidate mechanisms of adverse drug effects in the Cardiac Arrhythmia Suppression Trial.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Encainide; Flecainide; Heart Failure; Humans; Moricizine; Myocardial Infarction; Myocardial Ischemia; Risk Factors; Survival Analysis; Time Factors | 1995 |
Relations between heart failure, ejection fraction, arrhythmia suppression and mortality: analysis of the Cardiac Arrhythmia Suppression Trial.
Topics: Arrhythmias, Cardiac; Electrocardiography; Encainide; Female; Flecainide; Heart Failure; Humans; Male; Middle Aged; Moricizine; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Prognosis; Prospective Studies; Regression Analysis; Stroke Volume; Survival Analysis | 1995 |
Interaction of ischaemia and encainide/flecainide treatment: a proposed mechanism for the increased mortality in CAST I.
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Databases, Factual; Death, Sudden, Cardiac; Drug Interactions; Encainide; Flecainide; Heart Failure; Humans; Myocardial Infarction; Myocardial Ischemia; Retrospective Studies; Syncope; United States | 1995 |
Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.
Topics: Actuarial Analysis; Anilides; Arrhythmias, Cardiac; Electrocardiography; Encainide; Flecainide; Follow-Up Studies; Heart Arrest; Heart Failure; Humans; Morbidity; Myocardial Infarction; Patient Compliance | 1991 |
Events in the cardiac arrhythmia suppression trial: baseline predictors of mortality in placebo-treated patients.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chi-Square Distribution; Double-Blind Method; Encainide; Female; Flecainide; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Placebos; Proportional Hazards Models; Prospective Studies; Reference Values; Risk Factors | 1991 |
Comparative hemodynamic effects of procainamide, tocainide, and encainide in severe chronic heart failure.
Topics: Aged; Anilides; Anti-Arrhythmia Agents; Clinical Trials as Topic; Encainide; Female; Heart Failure; Hemodynamics; Humans; Lidocaine; Male; Procainamide; Random Allocation; Tocainide | 1990 |
Congestive heart failure after acute myocardial infarction in patients receiving antiarrhythmic agents for ventricular premature complexes (Cardiac Arrhythmia Pilot Study).
Topics: Anilides; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Double-Blind Method; Encainide; Female; Flecainide; Heart Failure; Humans; Imipramine; Male; Middle Aged; Moricizine; Myocardial Infarction; Phenothiazines; Random Allocation; Stroke Volume | 1989 |
The use of antiarrhythmic agents in heart failure: implications of CAST.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Encainide; Flecainide; Heart Failure; Hemodynamics; Humans; Risk Factors | 1989 |
Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Encainide; Female; Flecainide; Heart Failure; Humans; Imipramine; Male; Middle Aged; Moricizine; Myocardial Infarction; Phenothiazines; Random Allocation; Stroke Volume | 1988 |
4 other study(ies) available for encainide and Cardiac Failure
| Article | Year |
|---|---|
Adverse hemodynamic effects of antiarrhythmic drugs in congestive heart failure.
Topics: Anilides; Anti-Arrhythmia Agents; Encainide; Heart Failure; Hemodynamics; Humans; Lidocaine; Procainamide; Tocainide | 1990 |
Adverse hemodynamic and clinical effects of encainide in severe chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dyspnea; Encainide; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Stroke Volume | 1989 |
Congestive heart failure induced by six of the newer antiarrhythmic drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anilides; Anti-Arrhythmia Agents; Benzeneacetamides; Encainide; Female; Heart Failure; Humans; Lidocaine; Male; Mexiletine; Middle Aged; Moricizine; Phenothiazines; Piperidines; Propafenone; Risk Factors; Stroke Volume; Tocainide | 1989 |
Safety of encainide for the treatment of ventricular arrhythmias.
Topics: Aged; Anilides; Arrhythmias, Cardiac; Electrocardiography; Encainide; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Middle Aged; Retrospective Studies | 1986 |